4.8 Review

The human microbiome: A promising target for lung cancer treatment

期刊

FRONTIERS IN IMMUNOLOGY
卷 14, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2023.1091165

关键词

microbiome; pulmonary infection; immunology; clinical application; malignant mechanism; lung cancer

向作者/读者索取更多资源

Lung cancer is a major cause of cancer-related deaths worldwide, and understanding its mechanisms and potential treatments is crucial. The microbiome, through its involvement in inflammatory responses, immune regulation, metabolic disorders, and genotoxicity, plays a significant role in the initiation and progression of lung cancer. This comprehensive review examines the distribution and biological functions of the human microflora, the relationship between the microbiome and clinical characteristics, and the microbiome's role in the clinical treatment of lung cancer. It provides a valuable foundation for our current understanding of lung cancer mechanisms and informs future treatment decisions.
Lung cancer is the leading cause of cancer-related deaths worldwide, and insights into its underlying mechanisms as well as potential therapeutic strategies are urgently needed. The microbiome plays an important role in human health, and is also responsible for the initiation and progression of lung cancer through its induction of inflammatory responses and participation in immune regulation, as well as for its role in the generation of metabolic disorders and genotoxicity. Here, the distribution of human microflora along with its biological functions, the relationship between the microbiome and clinical characteristics, and the role of the microbiome in clinical treatment of lung cancer were comprehensively reviewed. This review provides a basis for the current understanding of lung cancer mechanisms with a focus on the microbiome, and contributes to future decisions on treatment management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据